Article
IL-27: a double agent in the IL-6 family.
Clinical and experimental immunology - 1 Jul 2018
Jones G W, Hill D G, Cardus A, Jones S A
Abstract excerpt
The cytokine interleukin (IL)-6 is a major therapeutic target for the treatment of various inflammatory and autoimmune diseases. While IL-6 receives considerable attention in studies of innate and adaptive immunity, the IL-6-related family member IL-27 is recognized increasingly for its effects on cellular proliferation, differentiation and leucocyte effector functions. Both cytokines activate responses in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
